These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19724920)

  • 1. The differential cell signaling effects of two positional isomers of the anticancer NO-donating aspirin.
    Hua A; Mackenzie GG; Rigas B
    Int J Oncol; 2009 Oct; 35(4):837-44. PubMed ID: 19724920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide-donating aspirin inhibits colon cancer cell growth via mitogen-activated protein kinase activation.
    Hundley TR; Rigas B
    J Pharmacol Exp Ther; 2006 Jan; 316(1):25-34. PubMed ID: 16169935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positional isomerism markedly affects the growth inhibition of colon cancer cells by nitric oxide-donating aspirin in vitro and in vivo.
    Kashfi K; Borgo S; Williams JL; Chen J; Gao J; Glekas A; Benedini F; Del Soldato P; Rigas B
    J Pharmacol Exp Ther; 2005 Mar; 312(3):978-88. PubMed ID: 15528453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positional isomerism markedly affects the growth inhibition of colon cancer cells by NOSH-aspirin: COX inhibition and modeling.
    Vannini F; Chattopadhyay M; Kodela R; Rao PPN; Kashfi K
    Redox Biol; 2015 Dec; 6():318-325. PubMed ID: 26319435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positional isomers of aspirin are equally potent in inhibiting colon cancer cell growth: differences in mode of cyclooxygenase inhibition.
    Kodela R; Chattopadhyay M; Goswami S; Gan ZY; Rao PP; Nia KV; Velázquez-Martínez CA; Kashfi K
    J Pharmacol Exp Ther; 2013 Apr; 345(1):85-94. PubMed ID: 23349335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphoaspirin (MDC-43), a novel benzyl ester of aspirin, inhibits the growth of human cancer cell lines more potently than aspirin: a redox-dependent effect.
    Zhao W; Mackenzie GG; Murray OT; Zhang Z; Rigas B
    Carcinogenesis; 2009 Mar; 30(3):512-9. PubMed ID: 19136474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitro-aspirin inhibits MCF-7 breast cancer cell growth: effects on COX-2 expression and Wnt/beta-catenin/TCF-4 signaling.
    Nath N; Vassell R; Chattopadhyay M; Kogan M; Kashfi K
    Biochem Pharmacol; 2009 Nov; 78(10):1298-304. PubMed ID: 19576865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide-donating aspirin induces apoptosis in human colon cancer cells through induction of oxidative stress.
    Gao J; Liu X; Rigas B
    Proc Natl Acad Sci U S A; 2005 Nov; 102(47):17207-12. PubMed ID: 16282376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation-stimulated ERK1/2 and JNK1/2 signaling can promote cell cycle progression in human colon cancer cells.
    Carón RW; Yacoub A; Mitchell C; Zhu X; Hong Y; Sasazuki T; Shirasawa S; Hagan MP; Grant S; Dent P
    Cell Cycle; 2005 Mar; 4(3):456-64. PubMed ID: 15655348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct effects of methylseleninic acid versus selenite on apoptosis, cell cycle, and protein kinase pathways in DU145 human prostate cancer cells.
    Jiang C; Wang Z; Ganther H; Lü J
    Mol Cancer Ther; 2002 Oct; 1(12):1059-66. PubMed ID: 12481429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells.
    Wang F; Li H; Yan XG; Zhou ZW; Yi ZG; He ZX; Pan ST; Yang YX; Wang ZZ; Zhang X; Yang T; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():575-601. PubMed ID: 25632225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth inhibition of human colon cancer cells by nitric oxide (NO)-donating aspirin is associated with cyclooxygenase-2 induction and beta-catenin/T-cell factor signaling, nuclear factor-kappaB, and NO synthase 2 inhibition: implications for chemoprevention.
    Williams JL; Nath N; Chen J; Hundley TR; Gao J; Kopelovich L; Kashfi K; Rigas B
    Cancer Res; 2003 Nov; 63(22):7613-8. PubMed ID: 14633677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanism of action of nitric oxide-donating aspirin.
    Kashfi K; Rigas B
    Biochem Biophys Res Commun; 2007 Jul; 358(4):1096-101. PubMed ID: 17512900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide-donating aspirin inhibits beta-catenin/T cell factor (TCF) signaling in SW480 colon cancer cells by disrupting the nuclear beta-catenin-TCF association.
    Nath N; Kashfi K; Chen J; Rigas B
    Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12584-9. PubMed ID: 14566053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo.
    Nath N; Chattopadhyay M; Rodes DB; Nazarenko A; Kodela R; Kashfi K
    Molecules; 2015 Jul; 20(7):12481-99. PubMed ID: 26184135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NOSH-Aspirin Inhibits Colon Cancer Cell Growth: Effects Of Positional Isomerism.
    Vannini F; Kodela R; Chattopadhyay M; Kashfi K
    Redox Biol; 2015 Aug; 5():421. PubMed ID: 28162291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin inhibits p44/42 mitogen-activated protein kinase and is protective against hypoxia/reoxygenation neuronal damage.
    Vartiainen N; Goldsteins G; Keksa-Goldsteine V; Chan PH; Koistinaho J
    Stroke; 2003 Mar; 34(3):752-7. PubMed ID: 12624303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide-donating aspirin induces G2/M phase cell cycle arrest in human cancer cells by regulating phase transition proteins.
    Gao L; Williams JL
    Int J Oncol; 2012 Jul; 41(1):325-30. PubMed ID: 22552812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
    Zhang YX; Kong CZ
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Cyclin-dependent kinase inhibitor CYC202 (R-roscovitine) inhibits retinoblastoma protein phosphorylation, causes loss of Cyclin D1, and activates the mitogen-activated protein kinase pathway.
    Whittaker SR; Walton MI; Garrett MD; Workman P
    Cancer Res; 2004 Jan; 64(1):262-72. PubMed ID: 14729633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.